(Press-News.org) Reston, Va.– A more precise method for determining bone marrow involvement in patients with diffuse large B-cell lymphoma (DLBCL)—a key factor in tailoring patient management plans—has been identified by researchers in a study published in the August issue of The Journal of Nuclear Medicine. Imaging with 18F-FDG positron emission tomography/computed tomography (PET/CT), when compared to bone marrow biopsy, was more sensitive, showed a higher negative predictive value and was more accurate, changing treatment for 42 percent of patients with bone marrow involvement.
DLBCL is the most frequent subtype of high-grade non-Hodgkin lymphoma, accounting for nearly 30 percent of all newly diagnosed cases in the United States. In recent decades, there has been a 150 percent increase in incidence of DLBCL.
"In our study, we showed that in diffuse large B-cell lymphoma, 18F-FDG PET/CT has better diagnostic performance than bone marrow biopsy to detect bone marrow involvement and provides a better prognostic stratification. While bone marrow biopsy is considered the gold standard to evaluate bone marrow involvement by high-grade lymphomas, 18F-FDG PET/CT is in fact the best method to evaluate extension of the disease, as well as avoid invasive procedures," said Louis Berthet, MD, lead author of the study "In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Dose Biopsy."
The retrospective study included 133 patients diagnosed with DLBCL. All patients received both a whole-body 18F-FDG PET/CT scan, as well as a bone marrow biopsy to determine bone marrow involvement. A final diagnosis of bone marrow involvement was made if the biopsy was positive, or if the positive PET/CT scan was confirmed by a guided biopsy, by targeted magnetic resonance imaging (MRI) or, after chemotherapy, by the concomitant disappearance of focal bone marrow uptake and uptake in other lymphoma lesions on 18F-FDG PET/CT reassessment. Progression-free survival and overall survival were then analyzed.
Thirty-three patients were considered to have bone marrow involvement. Of these, eight were positive according to the biopsy and 32 were positive according to the PET/CT scan.18FDG PET/CT was more sensitive (94 percent vs. 24 percent), showed a higher negative predictive value (98 percent vs. 80 percent) and was more accurate (98 percent vs. 81 percent) than bone marrow biopsy. Among the 26 patients with positive 18F-FDG PET/CT results and negative biopsy results, 11 were upstaged to stage IV by PET/CT, which changed their treatment plans. 18F-FDG PET/CT was also determined to be an independent predictor of progression-free survival.
"Our findings add to the literature to prove the significance of 18F-FDG PET/CT in cancer evaluation and to democratize this imaging method," said Berthet. "Molecular imaging is the best method to adapt targeted therapies to each patient. The emergence of PET/MRI and novel radiotracers predicts an exciting new future for our field.
###
Authors of the article "In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Dose Biopsy" include Louis Berthet, Salim Kanoun, Alina Berriolo-Riedinger, Michael Toubeau and Inna Dygai-Cochet, Department of Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France; Alexandre Cochet, Olivier Humbert and François Brunotte, Department of Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France, and Le21 UMR CNRS 5158, Dijon, France; and Caroline Legouge and Olivier Casasnovas, Department of Clinical Hematology, Centre Hospitalier Régional Universitaire, Hôspital Le Bocage, Dijon, France.
PET/CT bests gold standard bone marrow biopsy for diagnosis and prognosis of lymphoma patients
2013-08-01
ELSE PRESS RELEASES FROM THIS DATE:
Small protein plays big role in asthma severity
2013-08-01
Bethesda, MD—A new culprit has been identified that likely plays a big role in the severity of asthma—a small protein chemokine called CCL26. These findings were published in the Journal of Leukocyte Biology and represent the first demonstration that CCL26 is a potent regulator of the migration of asthmatic eosinophils, commonly observed in asthmatic airways. Results from this discovery may lead to new drug targets for the treatment of asthma.
"We hope that these studies will help to develop a new treatment that would specifically abrogate bronchial inflammation and ...
Study highlights possible new approach to prostate cancer treatment
2013-08-01
CINCINNATI -- A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer.
Conducted at Cincinnati Children's Hospital Medical Center, the research shows that expression of the FoxM1 protein is essential for prostate cancer to develop in mouse models. The study appears in the journal's Aug. 2 edition.
The study also shows that depletion of FoxM1 in prostate epithelial cells inhibits tumor cell proliferation, the process by which new blood vessels are formed, and metastasis -- the spread of cancer to other organs of ...
Inflammatory on and off switch identified for allergic asthma and COPD
2013-08-01
Bethesda, MD—Japanese researchers have made a new step toward understanding why—and how to stop—runaway inflammation for both chronic obstructive pulmonary disorder (COPD) and allergic asthma. In a new report appearing in the August 2013 issue of The FASEB Journal scientists show that two receptors of an inflammatory molecule, called "leukotriene B4," play opposing roles in turning inflammation on and off for allergic asthma and COPD. The first receptor, called "BLT1," promotes inflammation, while the second receptor, called "BLT2," has a potential to weaken inflammation ...
Study reveals target for drug development for chronic jaw pain disorder
2013-08-01
DURHAM, N.C. -- Temporomandibular joint disorder (TMJD) is the most common form of oral or facial pain, affecting over 10 million Americans. The chronic disorder can cause severe pain often associated with chewing or biting down, and lacks effective treatments.
In a study in mice, researchers at Duke Medicine identified a protein that is critical to TMJD pain, and could be a promising target for developing treatments for the disorder. Their findings are published in the August issue of the journal PAIN.
Aside from cases related to trauma, little is known about the ...
The endemic species of remarkable Fulgoromorpha from Iran
2013-08-01
In terms of biodiversity richness, Iran is considered as an extremely complex area with wide ranges in the extremes of altitude, climate and temperature. The high biodiversity of the Iranian fauna is also the result of its location and the influences of four ecozones from North, South and South East. The rather high number of recorded endemic species of Fulgoromorpha in Iran indicates a high potential for speciation in some areas.
More than 200 species of Fulgoromorpha have been recorded from Iran since 1902. Representatives from 13 families among those have never been ...
Extreme wildfires likely fueled by climate change
2013-08-01
EAST LANSING, Mich. -- Climate change is likely fueling the larger and more destructive wildfires that are scorching vast areas of the American West, according to new research led by Michigan State University scientists.
These erratic fires are harder to contain and often result in catastrophic damage and loss of property and life. Although not analyzed in the study, the recent Arizona wildfire that began with a lightning strike and killed 19 firefighters appeared to be such an unpredictable, fast-spreading blaze, according to a state report.
The MSU-led study, which ...
Fetal stress disrupts the way genes are transmitted
2013-08-01
Bethesda, MD -- If you think stress is killing you, you may be right, but what you don't know is that stress might have harmed your health even before you were born. In a new report appearing in the August 2013 issue of The FASEB Journal, Harvard researchers find that epigenetic disruptions, which are associated with chronic disease later in life, are already common at birth. Possibly, these aberrations result from stressors in the intrauterine environment (e.g. maternal smoking, maternal diet, or high levels of endocrine-disrupting chemicals). This finding supports the ...
Children with elevated blood pressure don't get recommended follow-up, few at risk for hypertension
2013-08-01
DENVER, Colo. -- Children who have a first elevated blood pressure at the doctor's office are not likely to receive the recommended follow-up blood pressure readings within a month, according to a study published today in Pediatrics. However, when the blood pressure was later repeated, most children's blood pressure returned to normal for their age, sex and height.
Authors of the study examined the electronic health records of 72,625 children and adolescents ages 3 to 17 over a three-year period at Kaiser Permanente in Colorado and Northern California, and HealthPartners ...
UPCI researchers target 'cell sleep' to lower chances of cancer recurrence
2013-08-01
PITTSBURGH, Aug. 1, 2013 – An international research team led by University of Pittsburgh Cancer Institute (UPCI) scientists discovered that by preventing cancer cells from entering a state of cellular sleep, cancer drugs are more effective, and there is a lower chance of cancer recurrence.
The findings, which will be published in the August 15 issue of the journal Cancer Research and are available online, are the first to show that it is possible to therapeutically target cancer cells to keep them from entering a cellular state called quiescence, or "cell sleep." Quiescence ...
A new tool for brain research
2013-08-01
Physicists and neuroscientists from The University of Nottingham and University of Birmingham have unlocked one of the mysteries of the human brain, thanks to new research using functional Magnetic Resonance Imaging (fMRI) and electroencephalography (EEG).
The work will enable neuroscientists to map a kind of brain function that up to now could not be studied, allowing a more accurate exploration of how both healthy and diseased brains work.
Functional MRI is commonly used to study how the brain works, by providing spatial maps of where in the brain external stimuli, ...